Tomorrow Investor

Menu
Tomorrow Investor
Food & Health
fileName-Moderna-Projects-1
Food & Health
Moderna Projects 1.9 Billion 2025 Sales, Cuts Cost Forecast
Jan. 12, 2026
Moderna (MRNA) expects 1.9 billion in 2025 sales while trimming its cost forecast, signaling improved operational efficiency amid COVID vaccine demand challenges. The updated revenue projection sits near the upper end of the biotech company’s previously announced range of 1.5 billion to 2.5 billion,...
➜
fileName-Amazon-Pharmacy-Adds-Novo-Nordisks-Wegovy-Weight-Loss-Pill-1767979736761
Food & Health
Amazon Pharmacy Adds Novo Nordisk's Wegovy Weight-Loss Pill
Jan. 9, 2026
Amazon Pharmacy (AMZN) began offering Novo Nordisk’s (NVO) newly FDA-approved Wegovy pill on Friday,...
fileName-GSKs-Hepatitis-B-Drug-Meets-Primary-Goals-in-Phase-III-Trials-1767794969640
Food & Health
GSK's Hepatitis B Drug Meets Primary Goals in Phase III Trials
Jan. 7, 2026
GSK (GSK.L) announced its experimental hepatitis B treatment bepirovirsen met primary endpoints in two...
fileName-Incyte-Blood-Cancer-Drug-Meets-Key-Trial-Goal-Shares-Rise-2
Food & Health
Incyte Blood Cancer Drug Meets Key Trial Goal, Shares Rise 2.3%
Jan. 5, 2026
Incyte (INCY.O) shares jumped 2.3% Monday after its experimental blood cancer combination therapy met...
fileName-Novo-Nordisk-Launches-Wegovy-Weight-Loss-Pill-at-149-Monthly-for-Self-Pay-Patients-1767621879883
Food & Health
Novo Nordisk Launches Wegovy Weight-Loss Pill at 149 Monthly for Self-Pay Patients
Jan. 5, 2026
Novo Nordisk (NVO) launched its oral Wegovy weight-loss pill Sunday at 149 monthly for self-pay patients,...
fileName-Drugmakers-Raise-Prices-on-350-Medicines-Despite-Trump-Pressure-1767189753604
Food & Health
Drugmakers Raise Prices on 350 Medicines Despite Trump Pressure
Dec. 31, 2025
Major pharmaceutical companies plan to raise U.S. prices on at least 350 branded medications in 2026...
fileName-Ultragenyx-Shares-Plunge-After-Bone-Disease-Drug-Fails-Late-Stage-Trials-1767016930954
Food & Health
Ultragenyx Shares Plunge After Bone Disease Drug Fails Late-Stage Trials
Dec. 29, 2025
Ultragenyx Pharmaceutical (RARE) shares tumbled after its experimental bone disease drug setrusumab failed...

Trending

fileName-Coca-Cola-Reshapes-Leadership-to-Speed-Digital-Transformation-1768399427498
Technology
Coca-Cola Reshapes Leadership to Speed Digital Transformation
Jan. 14, 2026
fileName-Climate-Activists-Target-BP-and-Shell-Over-Declining-Oil-Demand-Strategy-1768399501712
Energy
Climate Activists Target BP and Shell Over Declining Oil Demand Strategy
Jan. 14, 2026
fileName-Wells-Fargo-Profit-Climbs-6-on-Interest-Income-Boost-Despite-Stock-Decline-1768399569808
Finance
Wells Fargo Profit Climbs 6% on Interest Income Boost Despite Stock Decline
Jan. 14, 2026

CATEGORIES

Categories

SIGNUP TO OUR NEWSLETTER

Subscribe

Get breaking market insights directly to your inbox